These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30590624)

  • 21. Donor-derived infections, lessons learnt from the past, and what is the future going to bring us.
    Grossi PA
    Curr Opin Organ Transplant; 2018 Aug; 23(4):417-422. PubMed ID: 29916849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mathematical model to describe survival among liver recipients from deceased donors with risk of transmitting infectious encephalitis pathogens.
    Smalley HK; Anand N; Buczek D; Buczek N; Lin T; Rajore T; Wacker M; Basavaraju SV; Gurbaxani BM; Hammett T; Keskinocak P; Sokol J; Kuehnert MJ
    Transpl Infect Dis; 2019 Aug; 21(4):e13115. PubMed ID: 31102550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections.
    Len O; Garzoni C; Lumbreras C; Molina I; Meije Y; Pahissa A; Grossi P;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():10-8. PubMed ID: 24476053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Independent organ donor facilities: The future of organ donation?
    Bruzzone P
    Ann Ital Chir; 2014; 85(6):616-7. PubMed ID: 25919797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ten years of donor-derived disease: A report of the disease transmission advisory committee.
    Kaul DR; Vece G; Blumberg E; La Hoz RM; Ison MG; Green M; Pruett T; Nalesnik MA; Tlusty SM; Wilk AR; Wolfe CR; Michaels MG
    Am J Transplant; 2021 Feb; 21(2):689-702. PubMed ID: 32627325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis.
    Gourishankar S; Doucette K; Fenton J; Purych D; Kowalewska-Grochowska K; Preiksaitis J
    Transplantation; 2008 Apr; 85(7):980-5. PubMed ID: 18408578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea.
    La Y; Kwon DE; Yoo SG; Lee KH; Han SH; Song YG
    BMC Infect Dis; 2019 Nov; 19(1):948. PubMed ID: 31703564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receiving the Unwanted Gift: Infection Transmission through Organ Transplantation.
    Kirchner VA; Pruett TL
    Surg Infect (Larchmt); 2016 Jun; 17(3):318-22. PubMed ID: 27096745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid organ transplant donors with central nervous system infection.
    Kaul DR; Covington S; Taranto S; Green M; Lyon GM; Kusne S; Miller RA; Blumberg EA
    Transplantation; 2014 Sep; 98(6):666-70. PubMed ID: 24914569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology and prevention of donor-derived infections.
    Ison MG
    Adv Chronic Kidney Dis; 2009 Jul; 16(4):234-41. PubMed ID: 19576553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
    Pruett TL; Clark MA; Taranto SE
    Transplantation; 2017 Jul; 101(7):1670-1678. PubMed ID: 28252560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States.
    Kurihara C; Fernandez R; Safaeinili N; Akbarpour M; Wu Q; Budinger GRS; Bharat A
    Ann Thorac Surg; 2019 Apr; 107(4):1046-1052. PubMed ID: 30476471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus).
    Natov SN; Pereira BJ
    Transpl Infect Dis; 2002 Sep; 4(3):117-23. PubMed ID: 12421455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus.
    Len O; Los-Arcos I; Aguado JM; Blanes M; Bodro M; Carratalà J; Cordero E; Fariñas MC; Fernández-Ruiz M; Fortún J; Gavaldà J; López-Medrano F; López-Vélez R; Lumbreras C; Mahillo B; Marcos MÁ; Martin-Dávila P; Montejo JM; Moreno A; Muñoz P; Norman F; Pérez-Sáenz JL; Pumarola T; Sabé N; San-Juan R; Vidal E; Domínguez-Gil B;
    Transplant Rev (Orlando); 2020 Apr; 34(2):100528. PubMed ID: 32001103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG
    Clin Infect Dis; 1996 Aug; 23(2):292-7. PubMed ID: 8842266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.
    Selvey LA; Lim WH; Boan P; Swaminathan R; Slimings C; Harrison AE; Chakera A
    BMC Infect Dis; 2017 Jul; 17(1):501. PubMed ID: 28716027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of donor variables on heart transplantation outcomes in mechanically bridged versus standard recipients†.
    Urban M; Booth K; Jungschleger J; Netuka I; Schueler S; MacGowan G
    Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):455-464. PubMed ID: 30169835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cluster of donor-derived Cryptococcus neoformans infection affecting lung, liver, and kidney transplant recipients: Case report and review of literature.
    Camargo JF; Simkins J; Schain DC; Gonzalez AA; Alcaide ML; Anjan S; Guerra G; Roth D; Kupin WL; Mattiazzi A; Tan Y; Milikowski C; Morris MI; Abbo LM
    Transpl Infect Dis; 2018 Apr; 20(2):e12836. PubMed ID: 29359837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organ donor screening practices for Strongyloides stercoralis infection among US organ procurement organizations.
    Abanyie FA; Valice E; Delli Carpini KW; Gray EB; McAuliffe I; Chin-Hong PV; Handali S; Montgomery SP; Huprikar S
    Transpl Infect Dis; 2018 Jun; 20(3):e12865. PubMed ID: 29512242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplant Recipient Preferences Regarding Organ Donor Research: Their Role in Consent and use of Their Data.
    Lucas A; Strachan PH; D'Aragon F; Sarti AJ; Meade MO
    J Empir Res Hum Res Ethics; 2023 Oct; 18(4):296-303. PubMed ID: 37309124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.